[Successful induction of complete cytogenetic response with low-dose imatinib mesylate in an accelerated phase chronic myelogenous leukemia patient who developed severe bone marrow aplasia following standard-dose imatinib mesylate therapy].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples